Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × Injections × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 19 Myelodysplastic Syndromes 7 Carcinoma, Non-Small-Cell Lung 7 Leukemia, Myelomonocytic, Chronic 6 Advanced Solid Tumor 6 Triple Negative Breast Neoplasms 4 Neoplasms 4 Breast Neoplasms 4 Advanced Solid Tumour 4 Advanced Solid Tumors 4 Solid Tumor 3 Myeloproliferative Disorders 3 Sarcoma 2 Recurrence 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Monocytic, Acute 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Thrombocythemia, Essential 1

Interventions

Cisplatin 8 Pemetrexed 7 Carboplatin 4 Platinum 3 Nivolumab 3 Ipilimumab 3 1,2-diaminocyclohexaneplatinum II citrate 3 tremelimumab 2 pembrolizumab 2 durvalumab 2 Cyclophosphamide 2 methoxyamine 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 cediranib 1 bintrafusp alfa protein, human 1 atezolizumab 1 aldesleukin 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Pharmaceutical Preparations 1 Interleukin-2 1 In Situ Hybridization, Fluorescence 1 Imprint II 1 Immunoglobulin G 1 Gemcitabine 1 Etoposide 1 Disulfides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡